Search

everythinglearnresearchcommunity

for

Search:↓

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Hair transplantation is important for transgender patients to enhance their masculine or feminine appearance.

Hair transplantation can help transgender patients affirm their gender identity.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Transgender treatment includes hormones and surgery, but long-term effects are unknown and counseling is needed.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

The healthcare for transgender veterans could be better with a more unified team approach.

Finasteride effectively treats hair loss in transgender men with few side effects.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.